Jian-Ri Li

6PUBLICATIONS
20CO-AUTHORS
Infectious diseasesPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2026
Risk factors for mortality in prostatic abscess: Insights into patient characteristics and drainage practices.

|Mar 09, 2023
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics.

Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu

|Oct 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression.

Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt

|Jun 28, 2022
Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study.

Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen

|Jun 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).

Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov

|Oct 19, 2018
Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.

Jian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou

Pageof 1

Frequent Collaborators

1 joint publications

Jonathan E Rosenberg

1 joint publications

Se Hoon Park

1 joint publications

Tu V Dao

1 joint publications

Daniel Castellano